| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $260.0M | -19.3% |
| Cost of Revenue | $52.9M | -51.1% |
| Gross Profit | $207.1M | -3.1% |
| R&D Expense | $31.3M | -17.6% |
| SG&A Expense | $56.9M | -9.2% |
| Operating Income | -$40.6M | +43.5% |
| Pre-tax Income | -$40.0M | +43.9% |
| Income Tax | $29K | +52.6% |
| Net Income | -$77.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.9M | -43.2% |
| Accounts Receivable | $3.6M | -54.3% |
| Inventory | $690K | -95.6% |
| Current Assets | $56.9M | -39.4% |
| Total Assets | $171.2M | -31.5% |
| Current Liabilities | $61.5M | -19.8% |
| Long-term Debt | $18.2M | -17.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $6.6M | -58.8% |
| Financing Cash Flow | -$4.4M | -21.9% |
| -8.1% |
| EPS (Basic) | -$0.69 | -1.5% |
| EPS (Diluted) | -$0.69 | -1.5% |
| Total Liabilities |
| $114.9M |
| -21.3% |
| Stockholders' Equity | $56.3M | -45.8% |